|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | ||||||||
| Marketable securities | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Operating lease, right-of-use assets | ||||||||
| Property and equipment, net | ||||||||
| Deferred offering costs | ||||||||
| Other long-term assets | ||||||||
| Total assets | ||||||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Accrued expenses | ||||||||
| Operating lease liabilities, current | ||||||||
| Total current liabilities | ||||||||
| Operating lease liabilities, net of current portion | ||||||||
| Other liabilities | ||||||||
| Total liabilities | ||||||||
| Redeemable convertible preferred stock (Series A and B) and contingently redeemable restricted common stock | ||||||||
| Redeemable convertible preferred stock (Series A and B) | ||||||||
| Contingently redeemable restricted common stock | ||||||||
| Total redeemable convertible preferred stock (Series A and B) and contingently redeemable restricted common stock | ||||||||
| Stockholders’ equity: | ||||||||
| Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 28,963,858 and 28,729,725 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive loss | ||||||||
| Accumulated deficit | ||||||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity |
Loading...
